Fingerprint
Dive into the research topics where Amir A Jazaeri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy
Ma, X., Hsu, Y. C., Asare, A., Zhang, K., Glassman, D., Handley, K. F., Foster, K., Sharma, K., Westin, S., Jazaeri, A., Fleming, N. D., Bhattacharya, P. K., Jiang, X., Sood, A. K. & Shams, S., Dec 2025, In: Scientific reports. 15, 1, 14437.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial (Nature Medicine, (2025), 31, 7, (2365-2374), 10.1038/s41591-025-03650-6)
Wermke, M., Araujo, D. M., Chatterjee, M., Tsimberidou, A. M., Holderried, T. A. W., Jazaeri, A. A., Reshef, R., Bokemeyer, C., Alsdorf, W., Wetzko, K., Brossart, P., Aslan, K., Backert, L., Bunk, S., Fritsche, J., Gulde, S., Hengler, S., Hilf, N., Hossain, M. B. & Hukelmann, J. & 20 others, , Jul 2025, In: Nature medicine. 31, 7, p. 2453 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy (Nature, (2025), 644, 8076, (537-546), 10.1038/s41586-025-09203-8)
Dai, Y., Knisely, A., Yano, M., Dang, M., Hinchcliff, E. M., Lee, S., Welp, A., Chelvanambi, M., Lastrapes, M., Liu, H., Yuan, Z., Wang, C., Nie, H., Jean, S., Montaner, L. J., Hou, J., Patel, A., Patel, S., Fellman, B. & Yuan, Y. & 21 others, , Sep 25 2025, In: Nature. 645, 8082, p. E10Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial
Wermke, M., Araujo, D. M., Chatterjee, M., Tsimberidou, A. M., Holderried, T. A. W., Jazaeri, A. A., Reshef, R., Bokemeyer, C., Alsdorf, W., Wetzko, K., Brossart, P., Aslan, K., Backert, L., Bunk, S., Fritsche, J., Gulde, S., Hengler, S., Hilf, N., Hossain, M. B. & Hukelmann, J. & 20 others, , Jul 2025, In: Nature medicine. 31, 7, p. 2365-2374 10 p.Research output: Contribution to journal › Article › peer-review
Open Access23 Link opens in a new tab Scopus citations -
Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics
Liu, Y., Sinjab, A., Min, J., Han, G., Paradiso, F., Zhang, Y., Wang, R., Pei, G., Dai, Y., Liu, Y., Cho, K. S., Dai, E., Basi, A., Burks, J. K., Rajapakshe, K. I., Chu, Y., Jiang, J., Zhang, D., Yan, X. & Guerrero, P. A. & 10 others, , May 12 2025, In: Cancer cell. 43, 5, p. 905-924.e6Research output: Contribution to journal › Article › peer-review
90 Link opens in a new tab Scopus citations